Initial interim 52-week results from Phase 2b Population Extension cohort of PRISM clinical trial to be presented by Dante Pieramici, M.D., a ...

Axogen (AXGN) announced the appointment of Jesse Bishop as Vice President of Regulatory Affairs. Bishop will report to Michael Dale, President, ...

CARGO elects to discontinue FIRCE-1, a Phase 2 clinical study of firicabtagene autoleucel (firi-cel)1; Company believes results do not support a ...

Authors Trey Grainger, Doug Turnbull, Max Irwin, release book and create online hub to inspire, educate, and showcase new breakthroughs in ...

The firm this month introduced its platform-independent GPU-accelerated vector indexing feature. This service is said to delivers up to 10x faster index-building times while using GPUs that rival ...

Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines ...

ChatGPT-maker OpenAI unveiled a new logo, typeface (font), and color palette in a rebranding push. Although the changes are not very drastic, ...

Revenues increased 7.9% to $108.2 million in the third quarter of 2025 from $100.3 million in the third quarter of 2024;Organic growth of 3.5% ...

Business Insider deepens its business tech, and innovation coverage, with a focus on neutrality and quick, key updates for ambitious readers.

Xian Huang received a 2024 Global Recognition Award for advancing AI and financial technologies through innovative marketing.

without authorization from the trademark or brand owner False or misleading reference to any of the Business Insider Properties Advertising that uses the name or logo of any of the Business ...

“We are pleased to welcome Jesse to the Axogen team," said Michael Dale, Chief Executive Officer, and Director, Axogen. "His extensive experience in regulatory strategy and deep understanding of the ...